Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

316 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
Tiberti C, Giordano C, Locatelli M, Bosi E, Bottazzo GF, Buzzetti R, Cucinotta D, Galluzzo A, Falorni A, Dotta F. Tiberti C, et al. Among authors: buzzetti r. Diabetes. 2008 May;57(5):1276-83. doi: 10.2337/db07-0874. Epub 2008 Mar 10. Diabetes. 2008. PMID: 18332100 Free article.
High prevalence of advanced retinopathy in patients with type 2 diabetes from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study.
Pugliese G, Solini A, Zoppini G, Fondelli C, Zerbini G, Vedovato M, Cavalot F, Lamacchia O, Buzzetti R, Morano S, Nicolucci A, Penno G; Renal Insufficiency and Cardiovascular Events (RIACE) Study Group. Pugliese G, et al. Among authors: buzzetti r. Diabetes Res Clin Pract. 2012 Nov;98(2):329-37. doi: 10.1016/j.diabres.2012.09.006. Epub 2012 Sep 26. Diabetes Res Clin Pract. 2012. PMID: 23020932
Tyrosine phosphatase-related islet antigen 2(256-760) autoantibodies, the only marker of islet autoimmunity that increases by increasing the degree of BMI in obese subjects with type 2 diabetes.
Buzzetti R, Spoletini M, Zampetti S, Campagna G, Marandola L, Panimolle F, Dotta F, Tiberti C; NIRAD Study Group (NIRAD 8). Buzzetti R, et al. Diabetes Care. 2015 Mar;38(3):513-20. doi: 10.2337/dc14-1638. Epub 2015 Jan 7. Diabetes Care. 2015. PMID: 25567348 Free article.
Combination immunotherapies for type 1 diabetes mellitus.
Pozzilli P, Maddaloni E, Buzzetti R. Pozzilli P, et al. Among authors: buzzetti r. Nat Rev Endocrinol. 2015 May;11(5):289-97. doi: 10.1038/nrendo.2015.8. Epub 2015 Feb 17. Nat Rev Endocrinol. 2015. PMID: 25688000 Review.
Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience.
Maurizi AR, Suraci C, Pitocco D, Schiaffini R, Tubili C, Morviducci L, Giordano R, Manfrini S, Lauro D, Frontoni S, Pozzilli P, Buzzetti R; C.S.I.I. Study Group of Lazio Region Italy. Maurizi AR, et al. Among authors: buzzetti r. J Diabetes. 2016 Jan;8(1):41-4. doi: 10.1111/1753-0407.12321. Epub 2015 Oct 26. J Diabetes. 2016. PMID: 26118939
316 results